Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.
BACKGROUND: Clear cell renal cell carcinoma (CCRCC) is the commonest form of kidney cancer. Up to 91% have biallelic inactivation of VHL, resulting in stabilisation of HIF-α subunits. Factor inhibiting HIF-1 is an enzyme that hydroxylates HIF-α subunits and prevents recruitment of the co-activator C...
Main Authors: | Khan, M, Bhattacharyya, T, Andrikopoulos, P, Esteban, M, Barod, R, Connor, T, Ashcroft, M, Maxwell, P, Kiriakidis, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival
by: Kiriakidis, S, et al.
Published: (2015) -
Nuclear entry and export of FIH are mediated by HIF1α and exportin1 respectively
by: Wang, Y, et al.
Published: (2018) -
The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
by: Enfeng Wang, et al.
Published: (2014-01-01) -
Signalling cross talk of the HIF system: involvement of the FIH protein.
by: Coleman, M, et al.
Published: (2009) -
FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α
by: Jengmin Kang, et al.
Published: (2018-10-01)